Off-label use of ondansetron in pregnancy in Western Australia

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Colvin, Lyn ^a   Gill, Andrew W ^b   Slack Smith, Linda ^c   Stanley, Fiona J ^a   Bower, Carol ^a,d  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d Western Australian Register of Developmental Anomalies   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; ONDANSETRON;

ADULT; ARTICLE; AUSTRALIA; CONGENITAL DISORDER; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HYPEREMESIS GRAVIDARUM; MALE; MORNING SICKNESS; NEWBORN; OFF LABEL DRUG USE; PREGNANCY; PREGNANCY OUTCOME; RISK FACTOR;

ADULT; ANTIEMETICS; CONGENITAL ABNORMALITIES; FEMALE; HUMANS; HYPEREMESIS GRAVIDARUM; INFANT, NEWBORN; MALE; MORNING SICKNESS; OFF-LABEL USE; ONDANSETRON; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; RISK FACTORS; WESTERN AUSTRALIA;

EID: 84893719683     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/909860     Document Type: Article

References (47)

1. Women and Newborn Health Service, Early pregnancy care. Clinical Guidelines: 9. 6 Management of Hyperemesis Gravidarum 2012 Chapter 9 King Edward Memorial Hospital Section C: Gynaecology
2. American College of Obstetricians and Gynecologists, ACOG Practice Bulletin No. 52: nausea and vomiting of pregnancy. Obstetrics and Gynecology 2004 103 803 814
3. Gazmararian J. A., Petersen R., Jamieson D. J., Schild L., Adams M. M., Deshpande A. D., Franks A. L., Hospitalizations during pregnancy among managed care enrollees. Obstetrics and (Pubitemid 34722848)
4. Fejzo M. S., Ingles S. A., Wilson M., Wang W., MacGibbon K., Romero R., Goodwin T. M., High prevalence of severe nausea and vomiting of pregnancy and hyperemesis gravidarum among relatives of affected individuals. European Journal of Obstetrics Gynecology and Reproductive Biology 2008 141 1 13 17 2-s2.0-54849426625 10.1016/j.ejogrb.2008.07.003
5. Goodwin T. M., Hyperemesis gravidarum. Obstetrics and Gynecology Clinics of North America 2008 35 3 401 417 2-s2.0-49949088880 10.1016/j.ogc.2008.04.002
6. Outlaw W. M., Ibdah J. A., Koch K. L., Hyperemesis Gravidarum and Maternal Liver Disease 2000 Austin, Tex, USA Landes Bioscience Madame Curie Bioscience Database [Internet]
7. Bolin M., Akerud H., Cnattingius S., Stephansson O., Wikstrom A. K., Hyperemesis gravidarum and risks of placental dysfunction disorders: a population-based cohort study. An International Journal of Obstetrics and Gynaecology 2013 120 541 547
8. Therapeutic Goods Administration,. Product Information. Ondansetron. Australian Government Department of Health and Ageing, 2011
9. The Reproductive Toxicology Center. ReproTox. 2013, Copyright © 1994-2008, http://www.reprotox.org
10. Siu S.-S. N., Chan M. T. V., Lau T.-K., Placental transfer of ondansetron during early human pregnancy. Clinical Pharmacokinetics 2006 45 4 419 423 2-s2.0-33645511598 10.2165/00003088-200645040-00006
11. Therapeutic Goods Administration, Australian Categorisation System for Prescribing Medicines in Pregnancy 2011
12. Gazarian M., Kelly M., McPhee J. R., Graudins L. V., Ward R. L., Campbell T. J., Off-label use of medicines: consensus recommendations for evaluating appropriateness. Medical Journal of Australia 2006 185 10 544 548 2-s2.0-33751404911 (Pubitemid 44816941)
13. Rayburn W. F., Farmer K. C., Off-label prescribing during pregnancy. Obstetrics and Gynecology Clinics of North America 1997 24 3 471 478 2-s2.0-0030763093 10.1016/S0889-8545(05)70317-X (Pubitemid 27333099)
14. Herring C., McManus A., Weeks A., Off-label prescribing during pregnancy in the UK: an analysis of 18, 000 prescriptions in Liverpool Women's Hospital. International Journal of Pharmacy Practice 2010 18 4 226 229 2-s2.0-77954733593 10.1211/ijpp.18.04.0007
15. Australian Government Department of Health and Ageing. Schedule of Pharmaceutical Benefits, 2008
16. Australian Institute of Health and Welfare, Australia's Health 2006 2006 Canberra, Australia AIHW
17. Therapeutic Goods Administration. Australian Register of Therapeutic Goods Public Summary Entry 9978. Therapeutic Goods Administration, 1991
18. Australian Government Department of Health and Ageing. Schedule of Pharmaceutical Benefits, 2013
19. Raymond S. H., A survey of prescribing for the management of nausea and vomiting in pregnancy in Australasia. Australian and New Zealand Journal of Obstetrics and Gynaecology 2013 53 358 362
20. Guikontes E., Spantideas A., Diakakis J., Ondansetron and hyperemesis gravidarum. The Lancet 1992 340 8829, article 1223 2-s2.0-0026462548
21. Tincello D. G., Johnstone M. J., Treatment of hyperemesis gravidarum with the 5-HT3 antagonist ondansetron (Zofran). Postgraduate Medical Journal 1996 72 853 688 689 2-s2.0-0029804119 (Pubitemid 26392061)
22. Einarson A., Maltepe C., Navioz Y., Kennedy D., Tan M. P., Koren G., The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study. An International Journal of Obstetrics and Gynaecology 2004 111 9 940 943 2-s2.0-4544350744 10.1111/j.1471-0528.2004.00236.x (Pubitemid 39223043)
23. Asker C., Wikner B. N., Källén B., Use of antiemetic drugs during pregnancy in Sweden. European Journal of Clinical Pharmacology 2005 61 12 899 906 2-s2.0-29144525918 10.1007/s00228-005-0055-1 (Pubitemid 41803700)
24. Anderka M., Mitchell A. A., Louik C., Werler M. M., Hernández-Diaz S., Rasmussen S. A., Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects. Birth Defects Research Part A 2012 94 1 22 30 2-s2.0-84855944212 10.1002/bdra.22865
25. Ferreira E., Gillet M., Lelievre J., Bussieres J. F., Ondansetron use during pregnancy: a case series. Journal of Population Therapeutics and Clinical Pharmacology 2012 19 e1 e10
26. Pasternak B., Svanström H., Hviid A., Ondansetron in pregnancy and risk of adverse fetal outcomes. The New England Journal of Medicine 2013 368 814 823
27. Koren G., Is ondansetron safe for use during pregnancy? Canadian Family Physician 2012 58 1092 1093
28. US Food and Drug Administration, FDA Drug Safety Communication: Abnormal Heart Rhythms may be Associated with Use of Zofran (Ondansetron) 2011 Silver Spring, Md, USA US Food and Drug Administration
29. Holman C. D., Bass A. J., Rosman D. L., Smith M. B., Semmens J. B., Glasson E. J., Brook E. L., Trutwein B., Rouse I. L., Watson C. R., de Klerk N. H., Stanley F. J., A decade of data linkage in Western Australia: strategic design, applications and benefits of the WA data linkage system. Australian Health Review 2008 32 4 766 777 2-s2.0-58149216761 10.1071/AH080766
30. Colvin L., Slack-Smith L., Stanley F. J., Bower C., Pharmacovigilance in pregnancy using population-based linked datasets. Pharmacoepidemiology and Drug Safety 2009 18 3 211 225 2-s2.0-65249133151 10.1002/pds.1705
31. Colvin L., Slack-Smith L., Stanley F. J., Bower C., Linking a pharmaceutical claims database with a birth defects registry to investigate birth defect rates of suspected teratogens. Pharmacoepidemiology and Drug Safety 2010 19 11 1137 1150 2-s2.0-78049313187 10.1002/pds.1995
32. Holman C. D. J., Bass A. J., Rouse I. L., Hobbs M. S. T., Population-based linkage of health records in Western Australia: development of a health services research linked database. Australian and New Zealand Journal of Public Health 1999 23 5 453 459 2-s2.0-0032851098 (Pubitemid 29479210)
33. Bower C., Silva D., Henderson T. R., Ryan A., Rudy E., Ascertainment of birth defects: the effect on completeness of adding a new source of data. Journal of Paediatrics and Child Health 2000 36 6 574 576 2-s2.0-0033659150 10.1046/j.1440-1754.2000.00575.x
34. Giles G. G., Medical record linkage in Australia: this is as good as it gets. ANZ Journal of Surgery 2005 75 5, article 259 2-s2.0-21344496477 10.1111/j.1445-2197.2005.03412.x (Pubitemid 40826886)
35. Bower C., Stanley F. J., Western Australian congenital malformations register. Medical Journal of Australia 1983 2 4 189 191 2-s2.0-0020506622 (Pubitemid 13021714)
36. Bower C., Rudy E., Callaghan A., Quick J., Cosgrove P., Nassar N., Report of the Birth Defects Registry of Western Australia, 1980-2008 2009 Subiaco, Australia King Edward Memorial Hospital, Women and Newborn Health Service
37. Bower C., Rudy E., Callaghan A., Quick J., Nassar N., Age at diagnosis of birth defects. Birth Defects Research Part A 2010 88 4 251 255 2-s2.0-77950845421 10.1002/bdra.20658
38. Bower C., Rudy E., Quick J., Rowley A., Watson L., Cosgrove P., Report of the Western Australian Register of Developmental Anomalies 1980-2011 2012 Subiaco, Australia King Edward Memorial Hospital, Women and Newborn Health Service
39. British Paediatric Association. Classification of Diseases, Codes Designed for Use in the Classification of Paediatric and Perinatal Disorders. (Successor to the Cardiff Diagnostic Classification) A Paediatric Supplement Compatible with WHO International Classification of Diseases, 1977 1979 London, UK BPA
40. Blair E., Liu Y., Cosgrove P., Choosing the best estimate of gestational age from routinely collected population-based perinatal data. Paediatric and Perinatal Epidemiology 2004 18 4 270 276 2-s2.0-3343020772 10.1111/j.1365-3016. 2004.00562.x (Pubitemid 38993089)
41. Gee V., Hu Q. M., Ernstzen A. N., Perinatal Statistics in Western Australia, 2005. Proceedings of the 23rd Annual Report of the Western Australian Midwives' Notification System 2007 Perth, Australia Department of Health Western Australia
42. Blair E. M., Liu Y., de Klerk N. H., Lawrence D. M., Optimal fetal growth for the Caucasian singleton and assessment of appropriateness of fetal growth: an analysis of a total population perinatal database. BMC Pediatrics 2005 5, article 13 2-s2.0-26444456993 10.1186/1471-2431-5-13 (Pubitemid 41418294)
43. Milne E., Laurvick C. L., Blair E., Bower C., De Klerk N., Fetal growth and acute childhood leukemia: looking beyond birth weight. American Journal of Epidemiology 2007 166 2 151 159 2-s2.0-34547578403 10.1093/aje/kwm065 (Pubitemid 47227290)
44. Australian Bureau of Statistics, Socio-Economic Indexes for Areas (SEIFA). Information Paper 2001 Census of Population and Housing 2008 Canberra, Australia Commonwealth of Australia
45. Department of Health Western Australia, Hospital Morbdiity Data System Reference Manual July 2004 2004 Perth, Australia Health Data Collections Branch, Health Information Centre
46. Commonwealth of Australia. Schedule of Pharmaceutical Benefits for Approved Pharmacists and Medical Practitioners. August, 2003
47. Kallen B., Hyperemesis during pregnancy and delivery outcome: a registry study. European Journal of Obstetrics Gynecology and Reproductive Biology 1987 26 4 291 302 2-s2.0-0023264666 (Pubitemid 17163069)